Mitochondrial replacement techniques : ethical, social, and policy considerations /

Saved in:
Bibliographic Details
Imprint:Washington, D.C. : National Academies Press, [2016]
Description:1 online resource (1 PDF file (xvi, 184 pages)) : illustrations
Language:English
Series:Online access: NCBI NCBI Bookshelf.
Online access: National Academy of Sciences National Academies Press.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11254064
Hidden Bibliographic Details
Other authors / contributors:Claiborne, Anne B., editor.
English, Rebecca A., editor.
Kahn, Jeffrey P., editor.
Institute of Medicine (U.S.). Committee on the Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases, issuing body.
ISBN:9780309388702
0309388708
9780309388719
0309388716
Notes:Includes bibliographical references.
This activity was supported by Contract No. HHSP233201400020B/HHSP2337010 between the National Academy of Sciences and the U.S. Department of Health and Human Services, U.S. Food and Drug Administration. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project.
English.
Online resource; title from PDF title page (viewed May 27, 2016).
Summary:Mitochondrial replacement techniques (MRTs) are designed to prevent the transmission of mitochondrial DNA (mtDNA) diseases from mother to child. While MRTs, if effective, could satisfy a desire of women seeking to have a genetically related child without the risk of passing on mtDNA disease, the technique raises significant ethical and social issues. It would create offspring who have genetic material from two women, something never sanctioned in humans, and would create mitochondrial changes that could be heritable (in female offspring), and therefore passed on in perpetuity. The manipulation would be performed on eggs or embryos, would affect every cell of the resulting individual, and once carried out this genetic manipulation is not reversible. Mitochondrial Replacement Techniques considers the implications of manipulating mitochondrial content both in children born to women as a result of participating in these studies and in descendants of any female offspring. This study examines the ethical and social issues related to MRTs, outlines principles that would provide a framework and foundation for oversight of MRTs, and develops recommendations to inform the Food and Drug Administration's consideration of investigational new drug applications.
Other form:Print version: Mitochondrial replacement techniques. Washington, D.C. : National Academies Press, 2016 9780309388702

MARC

LEADER 00000cam a2200000 i 4500
001 11254064
005 20210426223755.3
006 m o d
007 cr cn|||||||||
008 160503s2016 dcua obt 000 0 eng
010 |a  2016933603 
016 7 |a 101683293  |2 DNLM 
019 |a 1021261991  |a 1144239970  |a 1162003355  |a 1229416640 
020 |a 9780309388702 
020 |a 0309388708 
020 |a 9780309388719 
020 |a 0309388716 
035 |a (OCoLC)945556529  |z (OCoLC)1021261991  |z (OCoLC)1144239970  |z (OCoLC)1162003355  |z (OCoLC)1229416640 
035 9 |a (OCLCCM-CC)945556529 
040 |a NLM  |b eng  |e rda  |e pn  |c NLM  |d MMU  |d N$T  |d YDXCP  |d OCLCO  |d EBLCP  |d IDB  |d MERUC  |d OCLCQ  |d OCLCO  |d OCLCA  |d BUF  |d SNK  |d DKU  |d AUW  |d MHW  |d IGB  |d D6H  |d OCLCF  |d VTS  |d EZ9  |d AGLDB  |d OCLCQ  |d G3B  |d S8J  |d S9I  |d VT2  |d STF  |d OCLCQ  |d NLM  |d OCLCO  |d UKAHL  |d OCLCO  |d OCLCA  |d SFB  |d LVT  |d OCLCO 
042 |a pcc 
043 |a n-us--- 
049 |a MAIN 
050 4 |a RG133.5 
060 0 0 |a 2016 E-349 
060 1 0 |a WQ 208 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
245 0 0 |a Mitochondrial replacement techniques :  |b ethical, social, and policy considerations /  |c Anne Claiborne, Rebecca English, Jeffrey Kahn, editors ; Committee on the Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases, Board on Health Sciences Policy, Institute of Medicine, National Academies of Sciences, Engineering, and Medicine. 
264 1 |a Washington, D.C. :  |b National Academies Press,  |c [2016] 
300 |a 1 online resource (1 PDF file (xvi, 184 pages)) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
504 |a Includes bibliographical references. 
520 3 |a Mitochondrial replacement techniques (MRTs) are designed to prevent the transmission of mitochondrial DNA (mtDNA) diseases from mother to child. While MRTs, if effective, could satisfy a desire of women seeking to have a genetically related child without the risk of passing on mtDNA disease, the technique raises significant ethical and social issues. It would create offspring who have genetic material from two women, something never sanctioned in humans, and would create mitochondrial changes that could be heritable (in female offspring), and therefore passed on in perpetuity. The manipulation would be performed on eggs or embryos, would affect every cell of the resulting individual, and once carried out this genetic manipulation is not reversible. Mitochondrial Replacement Techniques considers the implications of manipulating mitochondrial content both in children born to women as a result of participating in these studies and in descendants of any female offspring. This study examines the ethical and social issues related to MRTs, outlines principles that would provide a framework and foundation for oversight of MRTs, and develops recommendations to inform the Food and Drug Administration's consideration of investigational new drug applications. 
536 |a This activity was supported by Contract No. HHSP233201400020B/HHSP2337010 between the National Academy of Sciences and the U.S. Department of Health and Human Services, U.S. Food and Drug Administration. Any opinions, findings, conclusions, or recommendations expressed in this publication do not necessarily reflect the views of any organization or agency that provided support for the project. 
588 0 |a Online resource; title from PDF title page (viewed May 27, 2016). 
505 0 |a Introduction -- Science and policy context -- Do ethical, social, and policy considerations preclude MRT? -- Regulation and oversight of MRT in humans. 
546 |a English. 
650 0 |a Reproductive technology  |x Moral and ethical aspects  |z United States. 
650 0 |a Reproductive technology  |x Government policy  |z United States. 
650 0 |a Mitochondrial DNA  |x Abnormalities  |z United States. 
650 0 |a Mitochondrial pathology  |z United States. 
650 0 |a Medical ethics  |z United States. 
650 1 2 |a Mitochondrial Replacement Therapy  |x ethics. 
650 2 2 |a Mitochondrial Diseases  |x prevention & control. 
650 2 2 |a DNA, Mitochondrial. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Medical ethics.  |2 fast  |0 (OCoLC)fst01014081 
650 7 |a Mitochondrial DNA  |x Abnormalities.  |2 fast  |0 (OCoLC)fst01024019 
650 7 |a Mitochondrial pathology.  |2 fast  |0 (OCoLC)fst01024022 
650 7 |a Reproductive technology  |x Moral and ethical aspects.  |2 fast  |0 (OCoLC)fst01095010 
651 7 |a United States.  |2 fast  |0 (OCoLC)fst01204155 
655 4 |a Electronic books. 
700 1 |a Claiborne, Anne B.,  |e editor.  |0 http://id.loc.gov/authorities/names/no2011029945 
700 1 |a English, Rebecca A.,  |e editor.  |0 http://id.loc.gov/authorities/names/no2010177259 
700 1 |a Kahn, Jeffrey P.,  |e editor.  |0 http://id.loc.gov/authorities/names/n92804412 
710 2 |a Institute of Medicine (U.S.).  |b Committee on the Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases,  |e issuing body.  |0 http://id.loc.gov/authorities/names/n2016184975 
776 0 8 |i Print version:  |t Mitochondrial replacement techniques.  |d Washington, D.C. : National Academies Press, 2016  |z 9780309388702  |w (OCoLC)933521007 
830 0 |a Online access: NCBI NCBI Bookshelf. 
830 0 |a Online access: National Academy of Sciences National Academies Press. 
856 4 0 |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=1179498  |y eBooks on EBSCOhost 
856 4 0 |u http://dx.doi.org/10.17226/21871  |y National Academies Press 
903 |a HeVa 
929 |a oclccm 
999 f f |i 43438543-ec88-5a3b-8648-e0a8a26a5822  |s ff561c0d-4cba-5e6f-a5b2-d709c30a77ca 
928 |t Library of Congress classification  |a RG133.5  |l Online  |c UC-FullText  |u http://dx.doi.org/10.17226/21871  |z National Academies Press  |g ebooks  |i 12436803 
928 |t Library of Congress classification  |a RG133.5  |l Online  |c UC-FullText  |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=e000xna&AN=1179498  |z eBooks on EBSCOhost  |g ebooks  |i 12436802